Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 684.88M P/E - EPS this Y 37.00% Ern Qtrly Grth -
Income -77.26M Forward P/E -5.21 EPS next Y 21.30% 50D Avg Chg -1.00%
Sales 31.12M PEG -0.02 EPS past 5Y - 200D Avg Chg -21.00%
Dividend N/A Price/Book 3.68 EPS next 5Y 74.40% 52W High Chg -49.00%
Recommedations 2.90 Quick Ratio 6.40 Shares Outstanding 71.26M 52W Low Chg 68.00%
Insider Own 2.54% ROA -31.90% Shares Float 57.89M Beta 0.07
Inst Own 78.02% ROE -48.47% Shares Shorted/Prior 4.46M/4.87M Price 9.69
Gross Margin -233.22% Profit Margin -248.28% Avg. Volume 602,043 Target Price 1.84
Oper. Margin -672.69% Earnings Date Aug 5 Volume 227,498 Change -1.22%
About Aclaris Therapeutics, Inc.

Aclaris Therapeutics, Inc. a clinical-stage biopharmaceutical company, engages in the development of novel drug candidates for immune-inflammatory diseases in the United States. The company operates through two segments, Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing therapies to address significant unmet needs for immuno-inflammatory diseases. The Contract Research segment provides laboratory services. It develops Zunsemetinib (ATI-450), an MK2 inhibitor which is under Phase 1b/2 trials for the treatment of metastatic breast and pancreatic cancer; ATI-1777, a soft JAK 1/3 inhibitor, completed Phase 2b trails for the treatment of moderate to severe atopic dermatitis and other dermatologic conditions; and ATI-2138, an oral covalent inhibitor of ITK and JAK3 inhibitor under Phase 1 trials as a treatment for T cell-mediated autoimmune diseases. The company was incorporated in 2012 and is headquartered in Wayne, Pennsylvania.

Aclaris Therapeutics, Inc. News
06/06/24 Aclaris Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
05/10/24 Earnings Update: Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Just Reported And Analysts Are Boosting Their Estimates
05/08/24 Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Q1 2024 Earnings Call Transcript
05/08/24 Q1 2024 Aclaris Therapeutics Inc Earnings Call
05/08/24 Aclaris Therapeutics Inc (ACRS) Q1 2024 Earnings Call Transcript Highlights: Strategic Insights ...
05/07/24 Aclaris Therapeutics (ACRS) Reports Q1 Loss, Tops Revenue Estimates
05/07/24 Aclaris Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update
04/30/24 Aclaris Therapeutics to Announce First Quarter 2024 Financial Results onย May 7, 2024 and to Provide Corporate Update
04/23/24 Flare Therapeutics Appoints Douglas Manion, M.D., FRCP (C) as Chief Executive Officer
04/11/24 Favourable Signals For Aclaris Therapeutics: Numerous Insiders Acquired Stock
04/05/24 Are Medical Stocks Lagging Aclaris Therapeutics (ACRS) This Year?
03/20/24 Is Aclaris Therapeutics (ACRS) Stock Outpacing Its Medical Peers This Year?
03/04/24 Aclaris (ACRS) Upgraded to Buy: Here's Why
03/04/24 Is Aclaris Therapeutics (ACRS) Outperforming Other Medical Stocks This Year?
03/01/24 Aclaris Therapeutics Full Year 2023 Earnings: Beats Expectations
02/29/24 Analysts Have Just Cut Their Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Revenue Estimates By 51%
02/27/24 Aclaris Therapeutics (ACRS) Reports Q4 Loss, Tops Revenue Estimates
02/27/24 Aclaris Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update
02/27/24 Can Aclaris Therapeutics (NASDAQ:ACRS) Afford To Invest In Growth?
02/20/24 Pacira (PCRX) Earnings Expected to Grow: What to Know Ahead of Q4 Release
ACRS Chatroom

User Image GambitMentality Posted - 4 hours ago

Yesterday's #StockMarket Most Buying Insider trading led by $ACRS $TLYS and $JVA

User Image Trubach Posted - 6 hours ago

$ACRS Leonard Braden Michael is buying millions of shares ๐Ÿค” Very interesting

User Image insiderbuyingselling Posted - 1 day ago

$ACRS new insider buying: 1543434 shares. http://insiderbuyingselling.com/?t=ACRS

User Image Trubach Posted - 1 day ago

$ACRS wow so quiet here.

User Image Trubach Posted - 06/27/24

$ACRS what is going here? What are you guys waiting here for?

User Image RenaissanceTrading Posted - 06/24/24

$ACRS Good dip buy here

User Image RenaissanceTrading Posted - 06/24/24

$ACRS Swinging for a big move

User Image Market_Watch_CA Posted - 06/24/24

$ACRS A HUGE insider buy should be a great signal of what's coming and many on the sideline will be coming in. At some point soon, the shorts will have to cover.......

User Image Andersson17s Posted - 06/20/24

$ACRS There are many possible reasons for an insider to sell a stock, but only one reason to buy and that is to wait to make a lot of money. On Thursday, Braden Michael Leonard of Aclaris Therapeutics made a $1.78 million purchase of ACRS, purchasing 1,611,200 shares at $1.11 each...

User Image TheFlash Posted - 06/20/24

$ACRS $ACRS Huge insider buying on Form 4's Have a look 345k at $1.16 150k at 1.13 and 50k more at $1.13๐Ÿ‘€ SEC FORM 4

User Image JazzyJ03 Posted - 06/19/24

$ACRS

User Image Robeb7 Posted - 06/15/24

$ACRS that is a good Company ๐Ÿš€

User Image ShamiKabob Posted - 06/06/24

$ACRS I lied ๐Ÿ˜‚๐Ÿ˜‚

User Image ShamiKabob Posted - 06/06/24

$ACRS itโ€™s going to flyyyyy this month!

User Image kiboe Posted - 05/29/24

$ACRS ๐Ÿคฎ๐Ÿคฎ๐Ÿคฎ๐Ÿคฎ๐Ÿคฎ๐Ÿคฎ๐Ÿคฎ

User Image kiboe Posted - 05/28/24

$ACRS it appears it testing a $1

User Image Market_Watch_CA Posted - 05/27/24

$ACRS C'mon people, unlike most boards this board is too quiet and we need to be more active. The shorts have not covered yet and MM could run this back up on dime....

User Image kiboe Posted - 05/23/24

$ACRS forum is too quiet lol

User Image Jizzledrizzle Posted - 05/20/24

$ACRS โ€œIf we have the launch โ€œ more cash in the bank

User Image kiboe Posted - 05/20/24

$ACRS https://classic.clinicaltrials.gov/ct2/show/NCT06374459 ๐Ÿ‘๐Ÿฟ๐Ÿ™๐Ÿฟ๐Ÿ™๐Ÿฟ

User Image Beginner999 Posted - 05/17/24

$ACRS no one like her here hit $1.45$ later

User Image Jbz1011 Posted - 05/08/24

$ACRS up to 1.30??????????

User Image Jbz1011 Posted - 05/08/24

$ACRS Must've went through an dimensional shift after the last major acorn got busted

User Image Jbz1011 Posted - 05/08/24

$ACRS Why is it stating that after hr's is up to 1.30 when in fact it never hit 1.30 at all after hrs??? Strange..

User Image Daytrader1999 Posted - 05/08/24

$ACRS nice rebound

User Image kiboe Posted - 05/08/24

$ACRS Jesus when would this stock go up

User Image Jabed206 Posted - 05/08/24

$ACRS surprised its not down more

User Image wellhellomuse Posted - 05/07/24

$ACRS theyโ€™ve consistently beat earnings. Dont understand why the stock barely moves. This one confuses me. Is it volume that we need? ๐Ÿ˜ซ

User Image PARA_85 Posted - 05/07/24

$ACRS in ah

User Image Market_Watch_CA Posted - 05/07/24

$ACRS We should get some sort of short squeeze up to $2 imo....

Analyst Ratings
HC Wainwright & Co. Neutral Jan 22, 24
BTIG Neutral Jan 11, 24
HC Wainwright & Co. Buy Dec 29, 23
Stifel Hold Dec 18, 23
HC Wainwright & Co. Buy Nov 14, 23
Cantor Fitzgerald Neutral Nov 14, 23
Stifel Hold Nov 13, 23
William Blair Market Perform Nov 13, 23
Cantor Fitzgerald Overweight Oct 9, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Monahan Joseph Chief Scientific Off.. Chief Scientific Officer Oct 23 Sell 5.0767 6,000 30,460 129,724 10/25/23
Manion Douglas J. Pres and CEO Pres and CEO Mar 09 Buy 7.735 6,500 50,278 6,500 03/09/23
Walker Neal Director Director Mar 01 Sell 12.5 59,240 740,500 1,273,202 03/03/23
Monahan Joseph Chief Scientific Off.. Chief Scientific Officer Mar 01 Sell 12.5 30,837 385,462 147,724 03/03/23
Balthaser Kevin Chief Financial Offi.. Chief Financial Officer Mar 01 Sell 12.46 1,894 23,599 5,256 03/03/23
SCHIFF ANDREW N Director Director Nov 10 Sell 17.05 53,926 919,438 434,455 11/14/22
SCHIFF ANDREW N Director Director Oct 04 Sell 16.27 45,539 740,920 588,916 10/06/22
SCHIFF ANDREW N Director Director Jun 17 Sell 15.1428 19,565 296,269 06/21/22
Walker Neal President and CEO President and CEO Apr 21 Sell 15.15 70,000 1,060,500 1,245,763 04/25/22
Monahan Joseph Chief Scientific Off.. Chief Scientific Officer Apr 18 Sell 16.2766 30,000 488,298 106,386 04/20/22
Walker Neal President and CEO President and CEO Mar 11 Sell 15.9147 56,303 896,045 1,315,763 03/14/22
Ruffo Frank Chief Financial Offi.. Chief Financial Officer Mar 10 Sell 15.5451 12,823 199,335 201,883 03/14/22
Gordon David N. Chief Medical Office.. Chief Medical Officer Jun 02 Sell 22.51 51,914 1,168,584 144,078 06/02/21
Ali-Jackson Kamil Chief Legal Officer Chief Legal Officer Jun 02 Sell 22.32 45,119 1,007,056 131,688 06/02/21
Monahan Joseph Chief Scientific Off.. Chief Scientific Officer Jun 02 Sell 21.91 21,790 477,419 85,342 06/02/21
Ruffo Frank Chief Financial Offi.. Chief Financial Officer Jun 02 Sell 21.91 15,037 329,461 169,872 06/02/21
Walker Neal President and CEO President and CEO Jun 02 Sell 21.9 33,260 728,394 1,232,182 06/02/21
Ali-Jackson Kamil Chief Legal Officer Chief Legal Officer May 07 Option 10.66 20,416 217,635 149,034 05/07/21
Ali-Jackson Kamil Chief Legal Officer Chief Legal Officer May 07 Sell 23.6 20,416 481,818 143,618 05/07/21
Ruffo Frank Chief Financial Offi.. Chief Financial Officer Apr 26 Sell 26.61 87,339 2,324,091 151,720 04/26/21
Mehra Anand Director Director Feb 03 Option 18.34 14,632 268,351 30,841 02/03/21